期刊文献+

小剂量环孢素联合左旋咪唑治疗再生障碍性贫血临床价值探析 被引量:2

Small doses of ring spore element joint levamisole treatment of aplastic anemia clinical value
原文传递
导出
摘要 目的探讨小剂量环孢素与左旋咪唑联合应用于治疗再生障碍性贫血的,临床疗效。方法收集延安大学附属医院2013-012015-01收治的再生障碍性贫血患者96例,随机分为试验组与对照组各48例。对照组予以常规剂量环孢素5mg/(kg·d)治疗,试验组予以小剂量环孢素2mag/(kg·d)联合左旋咪唑100mg/d治疗,对比两组的治疗效果。结果试验纽的治疗总有效率为81.25%,高于对照组的75.00%;两组治疗后血红蛋白(Hb)及中性粒细胞(NEUT)均显著提高,P〈0.05;对照组的血小板计数(PLT)显著降低,而试验组显著提高,P〈0.05;试验组的不良反应率为2.08%,显著低于对照组的37.50%,P〈0.05。结论小剂量环孢素与左旋咪唑联合应用于治疗再生障碍性贫血具有显著疗效,且可减少环孢素用量及其不良反应,改善临床预后,值得推广应用。 OBJECTIVE To study the small dose of ring spore element and levamisole combined application in the clinical curative effect for the treatment of aplastic anemia. METHODS collecting 96 eases of aplastic anemia patients of our hospital were randomly divided into experimental group and control group (n= 48). Control group to regular doses of ring spore treatment, the treatment group to low-dose ring spore joint levamisole 100 mg/d treatment, compared two groups of treatment effect. RESULTS Treatment group total effective rate of 81.25% ,and 75.00% in the control group there was no significant difference; Two groups of Hb and NEUT are significantly improved after treatment (P〈0.05), no significant differences between groups (P〉0.05). CONCLUSION small dose of ring spore element and levamisole combined application in the treatment of aplastic anemia has significant curative effect,and can reduce ring spore consump- tion and its side effects, improve clinical outcomes.
作者 苏保雄
出处 《中华肿瘤防治杂志》 CAS 北大核心 2015年第B11期218-219,共2页 Chinese Journal of Cancer Prevention and Treatment
关键词 再生障碍性贫血 左旋咪唑 环孢素 小剂量 临床疗效 aplastic anemia levamisole cyclosporine low-doses clinical efficacy
  • 相关文献

参考文献3

二级参考文献39

  • 1[ No authors listed] Incidence of aplastic anemia: relevance of di- agnosis criteria. By the International Agranulocytosis and Aplastic Anemia Study. Blood, 1987, 70 : 1718-1721.
  • 2Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic ane- mia: a prospective study of the effect of early marrow transplanta- tion on acute mortality. Blood, 1976, 48:63-69.
  • 3Bacigalupo A, Hows J, Gluckman E, et aL Bone marrow trans- plantation (BMT) versus immunosuppression for the treatment of severe aplastic anemia (SAA) : a report of the EBMT SAA Work- ing Party. Br J Haematol, 1988, 70:177 -182.
  • 4British Commettee for Standards in Haematology, Blood transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol, 2003, 122 : 10-23.
  • 5Gluckman E, Esperou-Bourdeau H, Baruchel A, et al. Multi- center randomized study comparing cyclosporine-A alone and anti- thymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood, 1992, 79:2540 -2546.
  • 6Marsh J, Schrezenmeier H, Marin P, et al. Prospective random-ized muhicenter study comparing cyclosporin alone versus the com- bination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the Europe- an Blood and Marrow Transplant (EBMT) Severe Aplastic Anae- mia Working Party. Blood, 1999, 93:2191-2195.
  • 7Frickhofen N, Kahwasser JP, Schrezenmeier H, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylpred- nisolone with or without cyclosporine. The German Aplastic Ane- mia Study Group. N Engl J Med, 1991,324:1297-1304.
  • 8Frickhofen N, Heimpel H, Kahwasser JP, et al. Antithymocyte globulin with or without cyclosporine A : 11-year follow-up of ran- domized trial comparing treatments of aplastic anemia. Blood, 2003.101 : 1236-1242.
  • 9Song MK, Chung JS, Joo YD, et al. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia? Eur J Haematol, 2009,83:72-78.
  • 10del Mar Fem6ndez De Gatta M, Santos-Buelga D, Domtnguez-Gil A, et al. Immunosuppressive therapy for paediatric transplant patients : pharmacokinetic considerations. Clin Pharmacokinet, 2002,41 : 115-135.

共引文献34

同被引文献26

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部